+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 100Years
All Genders
ID06221488

Study of TB Infection Risk and Immune Response in Health Workers in Cape Town Using New and Established Tests Over One Year

Led by Beth Israel Deaconess Medical Center · Updated on 2026-07-08

300

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Tuberculosis TB is a major infectious disease affecting many people worldwide, including health workers in Cape Town, South Africa, who face a high risk of TB infection. This research is a prospective longitudinal study aiming to better understand TB infection by evaluating immune and pathogen responses over time in health workers using a combination of new and established tests. The study focuses on identifying which people exposed to TB may remain at risk for developing active TB disease, through detailed monitoring of their immune responses and infection markers. Participants in this study will undergo serial testing every 3 months for one year and again at 24 months using established and novel diagnostic tools. These tests include interferon gamma release assays IGRAs, blood RNA biosignatures, TB-specific antibody responses, and assays to detect TB DNA. The study will track changes in these markers over time to learn more about early infection, immune response dynamics, and potential infection clearance or persistence. During the study, health workers will be tested at months 0, 3, 6, 9, 12, and 24 to monitor TB infection status and detect any development of TB disease. Researchers will collect blood samples and perform various laboratory tests to measure immune markers and pathogen presence. The main outcome measured is IGRA conversion indicating new TB infection. Safety and health status will be monitored throughout participation, which may last over two years, to better understand TB infection progression in a population at high risk.

CONDITIONS

Brief Title

Testing Health Workers At Risk to Advance Our Understanding of TB Infection

Research Team

R

Ruvandhi Nathavitharana, MBBS MPH

G

Grant Theron, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here